Interleukin-4 induces human hepatocyte apoptosis through a Fas-independent pathway

FASEB Journal

Volumn 21, Issue 7, 2007, Pages 1433-1444

  Aoudjehane, Lynda ^a   Podevin, Philippe ^a   Scatton, Olivier ^b   Jaffray, Patrick ^b   Dusanter Fourt, Isabelle ^c   Feldmann, Gérard ^d   Massault, Pierre Philippe ^b   Grira, Lilia ^b   Bringuier, Annie ^d   Dousset, Bertrand ^b   Chouzenoux, Sandrine ^a   Soubrane, Olivier ^b   Calmus, Yvon ^a   Conti, Filomena ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b APHP ^*  (France)

^c INSTITUT COCHIN   (France)

^d INSERM   (France)

Author keywords

IL 4; Liver transplantation

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; FAS LIGAND; INTERLEUKIN 4; INTERLEUKIN 4 ANTIBODY; INTERLEUKIN 4 RECEPTOR; PROTEIN BAX; PROTEIN BID; SMALL INTERFERING RNA; STAT6 PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER CELL; LIVER GRAFT; LIVER INJURY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

HEPATITIS C VIRUS;

EID: 34247637682     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.06-6319com     Document Type: Article

References (60)

1. Conti, F., Dousset, B., Archambeau, D., Louvel, A., Houssin, D., and Calmus, Y. (1995) Enhanced risk of steroid-resistant acute rejection following pretransplant steroid therapy in liver graft recipients. Transplantation 60, 1104-1108
2. Shimoda, M., Ghobrial, R. M., Carmody, I. C., Anselmob, D. M., Farmer, D. G., Yersiz, H., Chen, P., Dawson, S., Durazo, F., Han, S., et al. (2004) Predictors of survival after liver transplantation for hepaocellular carcinoma associated with hepatitis C. Liver Transpl. 10, 1478-1486
3. Kornberg, A., Kupper, B., Tannapfel, A., Hommann, M., and Scheele, J. (2005) Impact of mycophenolate mofetil versus azathioprine on early recurrence of hepatitis C after Liver transplantation. Int. Immunopharmacol. 5, 107-115
4. Feray, C. (2004) Fibrosis progression after liver transplantation in patients with recurrent hepatitis C. J. Hepatol. 41, 862-863
5. Berenguer, M., Lopez-Labrador, F. X., and Wright, T. L. (2001) Hepatitis C and liver transplantation. J. Hepatol. 35, 666-678
6. Curry, M. P. (2004) Hepatitis B and hepatitis C viruses in liver transplantation. Transplantation 78, 955-963
7. Napoli, J., Bichop, G. A., Mcguinness, P. H., Painter, D. M., and Mccaughan, G. W. (1996) Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 24, 759-765
8. Bertoletti, A., D'Elios, M. M., Boni, C., De Carli, M., Zignego, A. L., Durazzo, M., Missale, G., Penna, A., Fiaccadori, F., Del Prete, G., et al. (1997) Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 112, 193-199
9. Thai, N. L., Fu, F., Qian, S., Sun, H., Gao, L., Wang, S. C., Demetris, A. J., Woo, J., Thomson, A. W., Duquesnoy, R. J., et al. (1995) Cytokine mRNA profiles in mouse orthotopic liver transplantation. Graft rejection is associated with augmented TH1 function. Transplantation 59, 274-281
10. Zekry, A., Bishop, G. A., Bowen, D. G., Gleeson, M. M., Guney, S., Painter, D. M., and McCaughan, G. W. (2002) Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury. Liver Transpl. 8, 292-301
11. Ramirez, F., Well, D. J., Puklavec, M., Simmonds, S., and Mason, D. (1996) Glucocorticoids promote a Th2 cytokine response by CD4+T cells in vitro. J. Immunol. 156, 2406-2412
12. Boleslawski, E., Conti, F., Sanquer, S., Podevin. P., Chouzenoux, S., Batteux, F., Houssin, D., Weill, B., and Calmus, Y. (2004) Defective inhibition of peripheral CD8+ T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection. Transplantation 77, 1815-1820
13. Conti, F., Calmus, Y., Rouer, E., Gaulard, P., Louvel, A., Zafrani, E. S., et al. (1999) Increased expression and role of interleukin-4 during liver allograft rejection. J. Hepatol. 30, 935-943
14. Ben Othman, S., Podevin, P., Aoudjehane, L., Chouzenoux, S., Batteux, F., Soubrane, O., Weill, B., Calmus, Y., and Conti, F. Increased production of interleukin-4 during severe recurrent hepatitis C after liver transplantation. Hepatology 42, 483A
15. Lee, Y. W., Eum, S. Y., Chen, K. C., Hennig, B., and Toborek, M. (2004) Gene expression profile in interleukin-4-stimulated human vascular endothelial cells. Mol. Med. 10, 19-27
16. Bouton, L. A., Ramirez, C. D., Bailey, D. P., Yeatman, C. F., Yue, J., Wright, H. V., Domen, J., Rosato, R. R., Grant, S., Fischer-Stenger, K. et al. (2004) Costimulation with interleukin-4 and interleukin-10 induces mast cell apoptosis and cell-cycle arrest: the role of p53 and the mitochondrion. Exp. Hematol. 32, 1137-1145
17. Talal, A. C. (2004) Interleukine-4 receptor signalling pathway in asthma pathogenosis. Trends Mol. Med. 10, 494-498
18. Wurster, A. L., Tanaka, T., and Grusby, M. J. (2000) The biology of Stat4 and Stat6. Oncogene 19, 2577-2584
19. Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J., and Paul, W. E. (1999) The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17, 701-738
20. Liu, K. D., Gaffen, S. L., and Goldsmith, M. A. (1998) JAK/STAT signaling by cytokine receptors. Curr. Opin. Immunol. 10, 271-278
21. Jiang, H., Harris, M. B., and Rothman, P. (2000) IL-4/IL-13 signaling beyond JAK/STAT. J. Allergy Clin. Immunol. 105, 1063-1070
22. Galka, E., Thompson, J., Zhang, W., Poritz, L. S., and Koltun, W. (2004) Stat6 null phenotype human lymphocytes exhibit increased apoptosis. J. Surg. Res. 122, 14-20
23. Kim, J., Cheon, I. S., Won, Y. J., Na, H. J., Kim, Y. M., and Choe, J. (2003) IL-4 inhibits cell cycle progression of human umbilical vein endothelial cells by affecting p53, p21Waf1, cyclin D1, and cyclin E. Expression. Mol. Cells 16, 92-96
24. Vella, V., Mineo, R., Frasca, F., Mazzon, E., Pandini, G., Vigneri, R., and Belfiore, A. (2004) Interleukin-4 stimulates papillary thyroid cancer cell survival: implications in patients with thyroid cancer and concomitant Graves' disease. J. Clin. Endocrinol. Metab. 89, 2880-2889
25. Lee, Y. W., Kuhn, H., and Henning, B. (2000) IL4 induces apoptosis of endothellial cells through the caspase-3-dependante pathway. FEBS Lett. 485, 122-126
26. Mangan, D. F., Robertson, B., Mangan, D. F., Robertson, B., and Wahl, S. M. (1992) IL-4 enhanced programmed cell death (apoptosis) in stimulated human monocytes. J. Immunol. 148, 1812-1816
27. Jaruga, B., Hong , F., and Sun, R. (2003) Crucial role of IL4 /STAT6 in T cell-mediated hepatitis: up-regulation eotaxin and IL5 and recruiting leukocytes. J. Immunol. 171, 3233-3244
28. Guillot, C., Coathalem, H., and Chetritt, J. (2001) Lethal hepatitis after Gene transfer of IL4 in the liver is independent of immune responses and dependant on apoptosis of hepatocytes: A rodent model of IL4-induced Hepatitis. J. Immunol. 166, 5225-5235
29. Gomez-Lechon, M. J., Serralta, A., Donato, M. T., Jimenez, N., OConnor, E., Castell, J. V., and Mir, J. (2004) The immunosuppressant drug FK506 prevents Fas- induced apoptosis in human hepatocytes. Biochem. Pharmacol. 68, 2427-2433
30. Rivero, M., Crespo, J., Mayorga, M., Fábrega, E., Casafont, F., and Pons-Romero, F. (2002) Involvement of the Fas system in liver allograft rejection. Am. J. Gastroenterol. 97, 1501-1506
31. McPartland, J. L., Guzail, M. A., Kendall, C. H., Pringle, J. H. (2005) Apoptosis in chronic viral hepatitis parallels histological activity: an immunohistochemical investigation using anti-activated caspase-3 and M30 cytodeath antibody. Int. J. Exp. Pathol. 86, 19-24
32. Kountouras, J., Zavos, C., and Chatzopoulos, D. (2003) Apoptosis in hepatitis C. J. Viral Hepat. 10, 335-342
33. Hillaire, S., Boucher, E., Calmus, Y., Gane, P., Ballet, F., Franco, D., Moukthar, M., and Poupon, R. (1994) Effects of bile acids and cholestasis on major histocompatibility complex class I in human and rat hepatocytes. Gastroenterology 107, 781-788
34. Van der Velden, V. H. J., Naber, B. A. E., Wierenga-Wolf, A. F., Debets, R., Savelkoul, H. F. J., Overbeek, S. E., Hoogsteden, H. C., and Versnel, M. (1998) Interleukin- 4 receptors on human bronchial epithelial cells. An in vivo and vitro analysis of expression and function. Cytokine 10, 803-813
35. De Leeuw, W. J., Slagboom, P. E., and Vijg, J. (1989) Quantitative comparison of mRNA levels in mammalian tissues: 28S ribosomal RNA level as an accurate internal control. Nucleic Acids Res. 23, 10137-10138
36. Conti, F., Frappier, J., Dharancy, S., Chereau, C., Houssin, D., Weill, B., and Calmus, Y. (2003) Interleukin-15 production during liver allograft rejection in humans. Transplantation 76, 210-216
37. Pallard, C., Gouilleux, F., Charon, M., Groner, B., Gisselbrecht, S., and Dusanter-Fourt, I. (1995) Interleukin-3, erythropoietin, and prolactin activate a STAT5-like factor in lymphoid cells. J. Biol. Chem. 270, 15942-15945
38. Guiter, C., Dusanter-Fourt, I., Copie-Bergman, C., Boulland, M. L., le Gouvello, S., Gaulard, P., Leroy, K., and Castellano, F. (2004) Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma. Blood 104, 543-549
39. Rippmann, J. F., Schnapp, A., Weith, A., and Hobbie, S. (2005) Gene silencing with STAT6 specific siRNAs blocks eotaxin release in IL-4/TNFα stimulated human epithelial cells. FEBS Lett. 579, 173-178
40. Chaloupka, R., Petit, P. X., Israel, N., and Sureau, F. (1999) Over-expression of Bcl-2 does not protect cells from hypericin photo-induced mitochondrial membrane depolarization, but delays subsequent events in the apoptotic pathway. FEBS Lett. 462, 295-301
41. Desagher, S., Osen-Sand, A., Nichols, A., Eskes, R., Montessuit, S., Lauper, S., Maundrell, K., Antonsson, B., and Martinou, J. C. (1999) Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol. 144, 891-901
42. Rudi, J., Kuck, D., Strand, S., Herbay, A., Mariani, S. M., Krammer, P. H., Galle, P. R., and Stremme, W. (1998) Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacterpylori-induced gastric epithelial apoptosis. J. Clin. Invest. 102, 1506-1514
43. Rajashekhar, G., Loganath, A., Roy, A. C., and Mongelli, J. M. (2003) Co-expression of Fas (APO-1, CD95)/Fas ligand by BeWo and NJG choriocarcinoma cell lines. Gynecol. Oncol. 91, 101-111
44. Lamboley, C., Bringuier, A. F., and Feldmann, G. (2000) apoptotic behaviour of hepatic and extra-hepatic tumor cell lines differs after fas stimulation. Cell. Mol. Biol. 46, 13-28
45. Muller, M., Strand, S., Hug, H., Heinemann, E. M., Walczak, H., Hofmann, W. J., et al. (1997) Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J. Clin. Invest. 99, 403-413
46. Petit, P. X., Lecoeur, H., Zorn, E., Dauguet, C., Mignotte, B., and Gougeon, M. L. (1995) Alterations of mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J. Cell Biol. 130, 157-167
47. Oskeritzian, C. A., Wang, Z., Kochan, J. P., Grimes, M., Du, Z., Chang, H. W., Grant, S., and Schwartz, L. B. (1999) Recombinant human (rh) IL-4-mediated apoptosis and recombinant human IL-6-mediated protection of recombinant human stem cell factor-dependent human mast cells derived from cord blood mononuclear cell progenitors. J. Immunol. 163, 5105-5115
48. Bailey, D. P., Kashyap, M., Mirmonsef, P., Bouton, L. A., Domen, J., Zhu, J., et al. (2004) Interleukin-4 elicits apoptosis of developing mast cells via a Stat6-dependent mitochondrial pathway. Exp. Hematol 32, 52-59
49. Parry, S., Hasbold, J., Holman, M., and Klaus, G. B. (1994) Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and Anti-CD40. J. Immunol. 152, 2821-2829
50. Higuchi, H., and Gores, G. J. (2003) Mechanisms of liver injury: an overview. Curr. Mol. Med. 3, 483-490
51. Ethier, M. F., and Madison, J. M. (2005) IL-4 inhibits calcium transients in bovine rachealis cells by a ryanodine receptor dependent mechanism. FASEB J. 20, 154-156
52. Li, B., Sun, R., Wei, H., Gao, B., and Tian, Z. (2006) Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism. Hepatology 43, 1211-1219
53. Rodrigues, D. B. R., Correia, D., Marra, M. D.., Giraldo, L. E., Lages-Silva, E., Silva-Vergara, M. L.., Barata, C., and Rodrigues, Jr., V. (2006) Cytokine serum levels in patients infected by human immunodeficiency virus with or without trypanosome cruzi coinfection. Rev. Soc. Bras. Med. Trop. 38, 483-487
54. Sasaki, Y., Mita, H., Toyota, M., Ishida, S., Morimoto, I., Yamashita, T., et al. (2003) Identification of the interleukin 4 receptor alpha gene as a direct target for p73. Cancer Res. 63, 8145-8152
55. Zuber, C. E., Galizzi, J. P., Harada, N., Durand, I., and Banchereau, J. (1990) Interleukin-4 receptors on human blood mononuclear cells. Cell. Immunol. 129, 329-340
56. Shi, Y. (2004) Caspase activation: revisiting the induced proximity model. Cell 117, 855-858
57. Juo, P., Kuo, C. J., Yuan, J., and Blenis, J. (1998) Essential requirement for caspase-8/FLICE in the initation of the Fasinduced apoptotic cascade. Curr. Biol. 8, 1001-1008
58. Bai, L., Cao, C. P., and Mao, G. P. (2004) Mechanism of hepatocytes apoptosis induced by the proapoptosis protein Bid. Chin. J. Dig. Dis. 5, 175-180
59. Eskes, R., Desagher, S., Antonsso, B., and Martinou, J. C. (2000) Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol. Cell. Biol. 20, 929-935
60. Wolter, K. G., Hsu, Y. T., Smith, C. L., Nechushtan, A., Xi, X. G., and al. (1997) Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139, 1281-1292